The 11th International Symposium on Targeted-Alpha-Therapy (TAT11) will provide information on the newest developments in preclinical studies, clinical experiences, dosimetry and instrumentation, quality assurance, regulatory, targeting, radiochemistry, and nuclide production and supply. Participate in the latest discussions, scientific exchange and in focused networking with industry leaders from around the world.

TAT11 will be held in Ottawa, Canada April 1-4th 2019. TAT11 is jointly organized by Canadian Nuclear Laboratories and TRIUMF. TAT11 continues a successful series of international symposia on this topic initiated by the Joint Research Centre of the European Commission, including meetings in Karlsruhe (1997, 2000), Heidelberg (2002), Düsseldorf (2004), Aachen (2007), Toronto (2009), Berlin (2011), Oak Ridge (2013), Warsaw (2015) and Kanazawa (2017).

Note: There are various registration options which may cause the cost to register for the events to vary.

For more information on the event, costs, and to register, CLICK HERE